A Granulomatous Drug Eruption Induced by Entecavir

Entecavir (Baraclude®, Bristol-Myers Squibb) is a potent and selective antiviral agent that has demonstrated efficacy in patients with chronic hepatitis B. The most frequent adverse events attributed to entecavir include increased alanine aminotransferase, upper respiratory tract infection, headache...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Jimi, Park, Donghwa, Kim, Chiyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870221/
https://www.ncbi.nlm.nih.gov/pubmed/24371400
http://dx.doi.org/10.5021/ad.2013.25.4.493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870221/
https://www.ncbi.nlm.nih.gov/pubmed/24371400
http://dx.doi.org/10.5021/ad.2013.25.4.493

Ejemplares similares